Talk to Us

38210 prior authorization | Anthem Blue Cross and Blue Shield Virginia

38210: Transplant Prep, Hematopoietic Progenitor Cells; Specfc Cell Deplet W/In Harvest, T-Cell Deplete. Imported Anthem Blue Cross and Blue Shield Virginia PPO source reference; confirm plan-specific review requirements in the original document. Not a coverage or referral decision.

Code
38210
Description
Transplant Prep, Hematopoietic Progenitor Cells; Specfc Cell Deplet W/In Harvest, T-Cell Deplete
Source
Virginia PPO standard precertification/prior authorization requirements, Pg 24 Original policy

Anthem Blue Cross and Blue Shield Virginia policies that name 38210

The payer's medical and payment policies that list 38210, those listing the fewest codes first. A policy can also list a code it excludes.

Search every Anthem Blue Cross and Blue Shield Virginia policy that names 38210

Anthem Blue Cross and Blue Shield Virginia prior authorization

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.

This website uses cookies to ensure you get the best experience on our website. Learn more